Dutch Firm Forbion Raises $2.6 Billion in Its Largest Fundraising Round
Dutch life sciences firm Forbion has closed two new funds with a total value of $2.6 billion, marking the largest fundraising in its history.
Listen to this story
Dutch life sciences investment firm Forbion has closed two new funds totaling €2.3 billion (around $2.6 billion) in the largest fundraising event in its history, as reported by VCWire.
The two funds are Forbion Growth Opportunities Fund IV, dedicated to late-stage companies, and Forbion Ventures Fund VIII, targeting early-stage companies, meaning the funds cover different stages of company development.
Investors in the funds include MN, PGGM, KfW Capital, the Kauffman Foundation, and Eli Lilly, representing a mix of pension funds, institutions, and pharmaceutical companies alongside other unnamed investors.
The firm manages around €7.5 billion in assets and states that the two new funds are capable of financing around 30 portfolio companies, with initial investments already completed, reflecting the scale of the firm's activity in the European market.
What do these terms mean?
Life Sciences: A sector comprising companies operating in pharmaceuticals, vaccines, and medical and biological technologies.
Investment Portfolio: The collection of companies in which a fund or investor holds investments simultaneously.
Growth Fund: A fund that invests in companies that have passed the startup phase and are seeking rapid expansion.
Weekly Newsletter
Read between the lines before everyone else. Decode the most important economic, tech, and decision-maker movements in the region.. in 5 minutes every Saturday.
